Works matching AU Call, Timothy G.

Results: 90
    1

    Differential transcriptomic profiling in ibrutinib‐naïve versus ibrutinib‐resistant Richter syndrome.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 2, p. 302, doi. 10.1002/hon.2950
    By:
    • Wang, Hanyin;
    • Tian, Shulan;
    • Zhao, Qing;
    • Blumenschein, Wendy;
    • Yearley, Jennifer H.;
    • Secreto, Charla R.;
    • Sinha, Sutapa;
    • Call, Timothy G.;
    • Wang, Yucai;
    • Parikh, Sameer A.;
    • Kenderian, Saad S.;
    • He, Rong;
    • Leis, Jose F.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Kay, Neil E.;
    • Slager, Susan L.;
    • Braggio, Esteban;
    • Yan, Huihuang;
    • Ding, Wei
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2022, v. 199, n. 2, p. 239, doi. 10.1111/bjh.18357
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Shi, Min;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 1, p. 143, doi. 10.1007/s00277-020-04094-3
    By:
    • Archibald, William J.;
    • Rabe, Kari G.;
    • Kabat, Brian F.;
    • Herrmann, Joerg;
    • Ding, Wei;
    • Kay, Neil E.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Chanan-Khan, Asher A.;
    • Schwager, Susan M.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Call, Timothy G.;
    • Parikh, Sameer A.
    Publication type:
    Article
    19
    20
    21

    The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 10, p. 3390, doi. 10.1002/cam4.2998
    By:
    • Parikh, Sameer A.;
    • Achenbach, Sara J.;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Chanan‐Khan, Asher A.;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Muchtar, Eli;
    • Fonder, Amie L.;
    • McCullough, Kristen B.;
    • Nedved, Adrienne N.;
    • Smith, Matthew D.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Finnes, Heidi D.;
    • Shanafelt, Tait D.
    Publication type:
    Article
    22

    Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0220-x
    By:
    • Clay-Gilmour, Alyssa I.;
    • Rishi, Abdul R.;
    • Goldin, Lynn R.;
    • Greenberg-Worisek, Alexandra J.;
    • Achenbach, Sara J.;
    • Rabe, Kari G.;
    • Maurer, Matthew J.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Call, Timothy G.;
    • Brice Weinberg, J.;
    • Camp, Nicola J.;
    • Cerhan, James R.;
    • Leis, Jose;
    • Norman, Aaron;
    • Murray, David L.;
    • Vincent Rajkumar, S.;
    • Caporaso, Neil E.;
    • Landgren, Ola;
    • McMaster, Mary L.
    Publication type:
    Article
    23
    24

    Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.

    Published in:
    British Journal of Haematology, 2018, v. 183, n. 3, p. 421, doi. 10.1111/bjh.15545
    By:
    • Hampel, Paul J.;
    • Larson, Melissa C.;
    • Kabat, Brian;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Bowen, Deborah;
    • Boysen, Justin;
    • Schwager, Susan M.;
    • Leis, Jose F.;
    • Chanan‐Khan, Asher A.;
    • Muchtar, Eli;
    • Hanson, Curtis A.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Chaffee, Kari G.;
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.
    Publication type:
    Article
    25

    Efficacy of biological agents in the treatment of Erdheim‐Chester disease.

    Published in:
    British Journal of Haematology, 2018, v. 183, n. 3, p. 520, doi. 10.1111/bjh.14997
    By:
    • Goyal, Gaurav;
    • Shah, Mithun V.;
    • Call, Timothy G.;
    • Litzow, Mark R.;
    • Wolanskyj‐Spinner, Alexandra P.;
    • Koster, Matthew J.;
    • Tobin, W. Oliver;
    • Vassallo, Robert;
    • Ryu, Jay H.;
    • Hook, Christopher C.;
    • Hogan, William J.;
    • Go, Ronald S.
    Publication type:
    Article
    26

    Human Pegivirus infection and lymphoma risk and prognosis: a North American study.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 5, p. 644, doi. 10.1111/bjh.15416
    By:
    • Fama, Angelo;
    • Xiang, Jinhua;
    • Link, Brian K.;
    • Allmer, Cristine;
    • Klinzman, Donna;
    • Feldman, Andrew L.;
    • Nowakowski, Grzegorz S.;
    • Liebow, Mark;
    • Larson, Melissa C.;
    • Maurer, Matthew J.;
    • Ansell, Stephen M.;
    • Novak, Anne J.;
    • Asmann, Yan W.;
    • Slager, Susan L.;
    • Call, Timothy G.;
    • Habermann, Thomas M.;
    • Cerhan, James R.;
    • Stapleton, Jack T.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33

    Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non- Hodgkin lymphoma subtypes.

    Published in:
    British Journal of Haematology, 2012, v. 159, n. 5, p. 572, doi. 10.1111/bjh.12070
    By:
    • Slager, Susan L.;
    • Camp, Nicola J.;
    • Conde, Lucia;
    • Shanafelt, Tait D.;
    • Achenbach, Sara J.;
    • Rabe, Kari G.;
    • Kay, Neil E.;
    • Novak, Anne J.;
    • Call, Timothy G.;
    • Bracci, Paige M.;
    • Sille, Fenna M. C.;
    • Sanchez, Sylvia;
    • Akers, Nicholas K.;
    • Cunningham, Julie M.;
    • Serie, Daniel J.;
    • McDonnell, Shannon K.;
    • Leis, Jose F.;
    • Wang, Alice H.;
    • Weinberg, J. Brice;
    • Glenn, Martha
    Publication type:
    Article
    34

    Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.

    Published in:
    British Journal of Haematology, 2010, v. 151, n. 2, p. 152, doi. 10.1111/j.1365-2141.2010.08339.x
    By:
    • Goldin, Lynn R.;
    • Lanasa, Mark C.;
    • Slager, Susan L.;
    • Cerhan, James R.;
    • Vachon, Celine M.;
    • Strom, Sara S.;
    • Camp, Nicola J.;
    • Spector, Logan G.;
    • Leis, Jose F.;
    • Morrison, Vicki A.;
    • Glenn, Martha;
    • Rabe, Kari G.;
    • Achenbach, Sara J.;
    • Algood, Sallie D.;
    • Abbasi, Fatima;
    • Fontaine, Laura;
    • Yau, Michelle;
    • Rassenti, Laura Z.;
    • Kay, Neil E.;
    • Call, Timothy G.
    Publication type:
    Article
    35
    36

    Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression.

    Published in:
    British Journal of Haematology, 2009, v. 147, n. 4, p. 471, doi. 10.1111/j.1365-2141.2009.07868.x
    By:
    • Ding, Wei;
    • Nowakowski, Grzegorz S.;
    • Knox, Traci R.;
    • Boysen, Justin C.;
    • Maas, Mary L.;
    • Schwager, Susan M.;
    • Wu, Wenting;
    • Wellik, Linda E.;
    • Dietz, Allan B.;
    • Ghosh, Asish K.;
    • Secreto, Charla R.;
    • Medina, Kay L.;
    • Shanafelt, Tait D.;
    • Zent, Clive S.;
    • Call, Timothy G.;
    • Kay, Neil E.
    Publication type:
    Article
    37
    38

    Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysis.

    Published in:
    Clinical Infectious Diseases, 2020, v. 71, n. 5, p. 1221, doi. 10.1093/cid/ciz940
    By:
    • Fama, Angelo;
    • Larson, Melissa C;
    • Link, Brian K;
    • Habermann, Thomas M;
    • Feldman, Andrew L;
    • Call, Timothy G;
    • Ansell, Stephen M;
    • Liebow, Mark;
    • Xiang, Jinhua;
    • Maurer, Matthew J;
    • Slager, Susan L;
    • Nowakowski, Grzegorz S;
    • Stapleton, Jack T;
    • Cerhan, James R
    Publication type:
    Article
    39
    40
    41

    Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Ailawadhi, Sikander;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Sher, Taimur;
    • Hanson, Curtis A.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    42

    Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00616-6
    By:
    • King, Rebecca L.;
    • Gupta, Alia;
    • Kurtin, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil. E.;
    • Koehler, Amber;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Habermann, Thomas M.;
    • Shi, Min;
    • Hanson, Curtis A.;
    • Howard, Matthew T.;
    • Parikh, Sameer A.
    Publication type:
    Article
    43
    44

    Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00477-5
    By:
    • Wang, Yucai;
    • Sinha, Sutapa;
    • Wellik, Linda E.;
    • Secreto, Charla R.;
    • Rech, Karen L.;
    • Call, Timothy G.;
    • Parikh, Sameer A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Hayman, Suzanne R.;
    • Koehler, Amber B.;
    • Van Dyke, Daniel L.;
    • Leis, Jose F.;
    • Slager, Susan L.;
    • Dong, Haidong;
    • Kay, Neil E.;
    • He, Rong;
    • Ding, Wei
    Publication type:
    Article
    45

    Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.

    Published in:
    2021
    By:
    • Hampel, Paul J.;
    • Parikh, Sameer A.;
    • Call, Timothy G.;
    • Shah, Mithun V.;
    • Bennani, N. Nora;
    • Al-Kali, Aref;
    • Rabe, Kari G.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Hanson, Curtis A.;
    • Van Dyke, Daniel L.;
    • Shi, Min;
    • Ding, Wei
    Publication type:
    Letter
    46
    47
    48
    49

    Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. E318, doi. 10.1002/ajh.27060
    By:
    • Kosydar, Samuel R.;
    • Parikh, Sameer A.;
    • Lester, Scott C.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Burlile, Jessica F.;
    • Kenderian, Saad S.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Call, Timothy G.;
    • Breen, William G.;
    • Hampel, Paul J.
    Publication type:
    Article
    50